Sacituzumab Govitecan / Trastuzumab Deruxtecan clinical trials

Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer

This study looks at two different drugs, sacituzumab govitecan and trastuzumab deruxtecan, for advanced triple-negative breast cancer. Researchers are testing if using them in an alternating pattern improves survival compared to using sacituzumab govitecan alone.